This theme aims to:

– Improve the quality, reliability, and accessibility of the evidence that underpins medications, devices, operations, and other therapeutic interventions

– Expose and challenging healthcare claims and regulatory failings that prioritise commercial interests over the interests of the public

– Improve understanding, transparency, and reporting of harms from medicines and other therapeutic interventions

Examples of our research in this area are shown below

Chlorogenic acids in green coffee & BP

Dozens of dietary supplements are marketed for blood pressure control, but the evidence for effectiveness for most is not established.

Read More

Device guided breathing for blood pressure control

The Resperate device is currently being marketed as a non-pharmacological treatment to lower blood pressure on the basis of a

Read More

Packaging to improve adherence

Researchers: Mahtani KR, Heneghan CJ, Glasziou PP, Perera R.

Read More

Tamiflu & Relenza: how effective are they?

Drug approval and use cannot be based on biased or missing information any longer. We risk too much in our population’s health and economy.

Read More